BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25933724)

  • 1. The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.
    Hulshof TA; Zuidema SU; Ostelo RW; Luijendijk HJ
    J Am Med Dir Assoc; 2015 Oct; 16(10):817-24. PubMed ID: 25933724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review.
    Luijendijk HJ; de Bruin NC; Hulshof TA; Koolman X
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):113-22. PubMed ID: 26601922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Haloperidol on Delirium in Adult Patients: A Systematic Review and Meta-Analysis.
    Shen YZ; Peng K; Zhang J; Meng XW; Ji FH
    Med Princ Pract; 2018; 27(3):250-259. PubMed ID: 29518791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.
    Pratt N; Roughead EE; Salter A; Ryan P
    BMC Med Res Methodol; 2012 Jun; 12():72. PubMed ID: 22682666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
    Schneider LS; Dagerman KS; Insel P
    JAMA; 2005 Oct; 294(15):1934-43. PubMed ID: 16234500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Run-in periods and clinical outcomes of antipsychotics in dementia: A meta-epidemiological study of placebo-controlled trials.
    Hulshof TA; Zuidema SU; Gispen-de Wied CC; Luijendijk HJ
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):125-133. PubMed ID: 31730266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials.
    Kishi T; Hirota T; Matsunaga S; Iwata N
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):767-74. PubMed ID: 26341326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics for Treating Delirium in Hospitalized Adults: A Systematic Review.
    Nikooie R; Neufeld KJ; Oh ES; Wilson LM; Zhang A; Robinson KA; Needham DM
    Ann Intern Med; 2019 Oct; 171(7):485-495. PubMed ID: 31476770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.
    Sacchetti E; Turrina C; Valsecchi P
    Drug Saf; 2010 Apr; 33(4):273-88. PubMed ID: 20297860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical antipsychotics for delirium in hospitalized patients].
    Bilicic Ubierna DB; Cattarinich Schiffrin N; Coronel Cárdenas D; Soto Munizaga R; Bernucci Piedra JM
    Medwave; 2021 May; 21(3):e8168. PubMed ID: 34037581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
    Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
    J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality Risk of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia: A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis of Randomized Controlled Trials.
    Yeh TC; Tzeng NS; Li JC; Huang YC; Hsieh HT; Chu CS; Liang CS
    J Clin Psychopharmacol; 2019; 39(5):472-478. PubMed ID: 31433335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature.
    Jeste DV; Dolder CR; Nayak GV; Salzman C
    Harv Rev Psychiatry; 2005; 13(6):340-51. PubMed ID: 16373328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics and the Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis of Observational Studies.
    Hsu WT; Esmaily-Fard A; Lai CC; Zala D; Lee SH; Chang SS; Lee CC
    J Am Med Dir Assoc; 2017 Aug; 18(8):692-699. PubMed ID: 28431909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials.
    Kishi T; Matsunaga S; Iwata N
    Schizophr Bull; 2016 Nov; 42(6):1438-1445. PubMed ID: 27086079
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.